TELA Bio Inc. (TELA)
0.73
+0.01 (1.39%)
Upcoming Events
Latest Headlines
TELA Bio to Announce Second Quarter 2026 Financial Results
July 20, 2026 4:05 PM - StreetInsider
Form 4 TELA Bio, Inc. For: Jul 15 Filed by: Plovanic William J.
July 17, 2026 5:30 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jul 15 Filed by: Capper Joseph H
July 17, 2026 5:30 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jun 09 Filed by: Rocchio Betty Jo
June 11, 2026 6:14 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jun 09 Filed by: Capper Joseph H
June 11, 2026 6:11 PM - SEC Filing
Form 3 TELA Bio, Inc. For: Jun 09 Filed by: Capper Joseph H
June 11, 2026 6:10 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jun 09 Filed by: Plovanic William J.
June 11, 2026 6:10 PM - SEC Filing
Form 3 TELA Bio, Inc. For: Jun 09 Filed by: NEELS GUIDO J
June 11, 2026 6:08 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jun 09 Filed by: NEELS GUIDO J
June 11, 2026 6:08 PM - SEC Filing
Form 3 TELA Bio, Inc. For: Jun 09 Filed by: THOMAS PAUL
June 11, 2026 6:07 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jun 09 Filed by: THOMAS PAUL
June 11, 2026 6:06 PM - SEC Filing
Form 3 TELA Bio, Inc. For: Jun 09 Filed by: NOHRA GUY P
June 11, 2026 6:05 PM - SEC Filing
Form 4 TELA Bio, Inc. For: Jun 09 Filed by: NOHRA GUY P
June 11, 2026 6:04 PM - SEC Filing
Form 8-K TELA Bio, Inc. For: Jun 09
June 11, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13D TELA Bio, Inc. Filed by: EW HEALTHCARE PARTNERS FUND 2, L.P.
June 9, 2026 6:29 PM - SEC Filing
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026 9:00 AM - StreetInsider
Form SCHEDULE 13G/A TELA Bio, Inc. Filed by: LYTTON LAURENCE W
May 15, 2026 1:05 PM - SEC Filing
Form 10-Q TELA Bio, Inc. For: Mar 31
May 13, 2026 4:07 PM - SEC Filing
TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c
May 12, 2026 5:12 PM - StreetInsider
Form 8-K TELA Bio, Inc. For: May 12
May 12, 2026 4:11 PM - SEC Filing
TELA Bio Reports First Quarter 2026 Financial Results
May 12, 2026 4:05 PM - StreetInsider
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 7, 2026 4:05 PM - StreetInsider
Form ARS TELA Bio, Inc. For: Dec 31
April 30, 2026 5:08 PM - SEC Filing
Form DEFA14A TELA Bio, Inc.
April 30, 2026 5:06 PM - SEC Filing
Form DEF 14A TELA Bio, Inc. For: Jun 09
April 30, 2026 5:01 PM - SEC Filing
Form 8-K TELA Bio, Inc. For: Apr 29
April 30, 2026 4:58 PM - SEC Filing
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter
April 30, 2026 4:43 PM - Globe NewsWire
Full Article List